Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Cystic fibrosis is a genetic disease that causes continuous lung infections and breathing problem over time. It is a progressive disease. The presence of imperfect gene causes a thick, sticky buildup of mucus in the lungs, intestine liver, pancreas, and other organs. The mucus in the lungs clogs airways and traps bacteria leading to infections that causes savior lung damage, and respiratory failure. The mucus prevents in the pancreas discharge the digestive enzymes that allow the body to break down food and absorb vital nutrients. This disease is caused by mutation in gene, cystic fibrosis trans membrane conductance regulator (CFTR) is a membrane protein in vertebrates, a protein required for regulating sweat, mucus and body secretions.
The report details the trend, potential and market size of Cystic Fibrosis (CF) Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Cystic Fibrosis (CF) Therapeuticsmarket, defines the market attractiveness level of Cystic Fibrosis (CF) Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Cystic Fibrosis (CF) Therapeutics industry, describes the types of Cystic Fibrosis (CF) Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cystic Fibrosis (CF) Therapeutics market and the development prospects and opportunities of Cystic Fibrosis (CF) Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cystic Fibrosis (CF) Therapeutics market in Chapter 13.
By Player:
AstraZeneca
Gilead
AIT (Advanced Inhalation Therapies)
Alcresta
Teva Pharmaceutical Industries Ltd
ALLERGAN
Novartis AG
Alaxia
Vertex Pharmaceuticals Incorporated
By Type:
Pancreatic enzyme supplements
Mucolytics
Bronchodilators
CFTR modulators
By End-User:
Oral drugs
Inhaled drugs
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Cystic Fibrosis (CF) Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Cystic Fibrosis (CF) Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Cystic Fibrosis (CF) Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Cystic Fibrosis (CF) Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Cystic Fibrosis (CF) Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Cystic Fibrosis (CF) Therapeutics Consumption (2017-2022)
-
7.2 United States Cystic Fibrosis (CF) Therapeutics Consumption (2017-2022)
-
7.3 Europe Cystic Fibrosis (CF) Therapeutics Consumption (2017-2022)
-
7.4 China Cystic Fibrosis (CF) Therapeutics Consumption (2017-2022)
-
7.5 Japan Cystic Fibrosis (CF) Therapeutics Consumption (2017-2022)
-
7.6 India Cystic Fibrosis (CF) Therapeutics Consumption (2017-2022)
-
7.7 South Korea Cystic Fibrosis (CF) Therapeutics Consumption (2017-2022)
8 Region and Country-wise Cystic Fibrosis (CF) Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Cystic Fibrosis (CF) Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Cystic Fibrosis (CF) Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Cystic Fibrosis (CF) Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Cystic Fibrosis (CF) Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Cystic Fibrosis (CF) Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Cystic Fibrosis (CF) Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Cystic Fibrosis (CF) Therapeutics Consumption Forecast (2022-2028)
9 Global Cystic Fibrosis (CF) Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Cystic Fibrosis (CF) Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Pancreatic enzyme supplements Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Mucolytics Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Bronchodilators Consumption and Growth Rate (2017-2022)
-
9.1.4 Global CFTR modulators Consumption and Growth Rate (2017-2022)
-
9.2 Global Cystic Fibrosis (CF) Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Oral drugs Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Inhaled drugs Consumption and Growth Rate (2017-2022)
10 Global Cystic Fibrosis (CF) Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Cystic Fibrosis (CF) Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Pancreatic enzyme supplements Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Mucolytics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Bronchodilators Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global CFTR modulators Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Cystic Fibrosis (CF) Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Oral drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Inhaled drugs Consumption Forecast and Growth Rate (2022-2028)
11 Global Cystic Fibrosis (CF) Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Cystic Fibrosis (CF) Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Cystic Fibrosis (CF) Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Cystic Fibrosis (CF) Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Cystic Fibrosis (CF) Therapeutics Market Competitive Analysis
-
14.1 AstraZeneca
-
14.1.1 AstraZeneca Company Details
-
14.1.2 AstraZeneca Cystic Fibrosis (CF) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 AstraZeneca Cystic Fibrosis (CF) Therapeutics Product and Service
-
14.2 Gilead
-
14.2.1 Gilead Company Details
-
14.2.2 Gilead Cystic Fibrosis (CF) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Gilead Cystic Fibrosis (CF) Therapeutics Product and Service
-
14.3 AIT (Advanced Inhalation Therapies)
-
14.3.1 AIT (Advanced Inhalation Therapies) Company Details
-
14.3.2 AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Product and Service
-
14.4 Alcresta
-
14.4.1 Alcresta Company Details
-
14.4.2 Alcresta Cystic Fibrosis (CF) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Alcresta Cystic Fibrosis (CF) Therapeutics Product and Service
-
14.5 Teva Pharmaceutical Industries Ltd
-
14.5.1 Teva Pharmaceutical Industries Ltd Company Details
-
14.5.2 Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics Product and Service
-
14.6 ALLERGAN
-
14.6.1 ALLERGAN Company Details
-
14.6.2 ALLERGAN Cystic Fibrosis (CF) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 ALLERGAN Cystic Fibrosis (CF) Therapeutics Product and Service
-
14.7 Novartis AG
-
14.7.1 Novartis AG Company Details
-
14.7.2 Novartis AG Cystic Fibrosis (CF) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Novartis AG Cystic Fibrosis (CF) Therapeutics Product and Service
-
14.8 Alaxia
-
14.8.1 Alaxia Company Details
-
14.8.2 Alaxia Cystic Fibrosis (CF) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Alaxia Cystic Fibrosis (CF) Therapeutics Product and Service
-
14.9 Vertex Pharmaceuticals Incorporated
-
14.9.1 Vertex Pharmaceuticals Incorporated Company Details
-
14.9.2 Vertex Pharmaceuticals Incorporated Cystic Fibrosis (CF) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Vertex Pharmaceuticals Incorporated Cystic Fibrosis (CF) Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Cystic Fibrosis (CF) Therapeutics
-
Figure Cystic Fibrosis (CF) Therapeutics Picture
-
Table Global Cystic Fibrosis (CF) Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cystic Fibrosis (CF) Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cystic Fibrosis (CF) Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Cystic Fibrosis (CF) Therapeutics Consumption by Country (2017-2022)
-
Figure United States Cystic Fibrosis (CF) Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Cystic Fibrosis (CF) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Cystic Fibrosis (CF) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Cystic Fibrosis (CF) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Cystic Fibrosis (CF) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Cystic Fibrosis (CF) Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Cystic Fibrosis (CF) Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Cystic Fibrosis (CF) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Cystic Fibrosis (CF) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Cystic Fibrosis (CF) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Cystic Fibrosis (CF) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Cystic Fibrosis (CF) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Cystic Fibrosis (CF) Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pancreatic enzyme supplements Consumption and Growth Rate (2017-2022)
-
Figure Global Mucolytics Consumption and Growth Rate (2017-2022)
-
Figure Global Bronchodilators Consumption and Growth Rate (2017-2022)
-
Figure Global CFTR modulators Consumption and Growth Rate (2017-2022)
-
Figure Global Oral drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Inhaled drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Pancreatic enzyme supplements Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Mucolytics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bronchodilators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CFTR modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Inhaled drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Cystic Fibrosis (CF) Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Cystic Fibrosis (CF) Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Cystic Fibrosis (CF) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Cystic Fibrosis (CF) Therapeutics Product and Service
-
Table Gilead (Foundation Year, Company Profile and etc.)
-
Table Gilead Cystic Fibrosis (CF) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Cystic Fibrosis (CF) Therapeutics Product and Service
-
Table AIT (Advanced Inhalation Therapies) (Foundation Year, Company Profile and etc.)
-
Table AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AIT (Advanced Inhalation Therapies) Cystic Fibrosis (CF) Therapeutics Product and Service
-
Table Alcresta (Foundation Year, Company Profile and etc.)
-
Table Alcresta Cystic Fibrosis (CF) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alcresta Cystic Fibrosis (CF) Therapeutics Product and Service
-
Table Teva Pharmaceutical Industries Ltd (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Industries Ltd Cystic Fibrosis (CF) Therapeutics Product and Service
-
Table ALLERGAN (Foundation Year, Company Profile and etc.)
-
Table ALLERGAN Cystic Fibrosis (CF) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table ALLERGAN Cystic Fibrosis (CF) Therapeutics Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Cystic Fibrosis (CF) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Cystic Fibrosis (CF) Therapeutics Product and Service
-
Table Alaxia (Foundation Year, Company Profile and etc.)
-
Table Alaxia Cystic Fibrosis (CF) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alaxia Cystic Fibrosis (CF) Therapeutics Product and Service
-
Table Vertex Pharmaceuticals Incorporated (Foundation Year, Company Profile and etc.)
-
Table Vertex Pharmaceuticals Incorporated Cystic Fibrosis (CF) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vertex Pharmaceuticals Incorporated Cystic Fibrosis (CF) Therapeutics Product and Service
-
